SOUTHAMPTON scientists have made a major breakthrough that could help patients with mesothelioma survive for longer.
Mesothelioma is an aggressive form of cancer that is linked to breathing in asbestos fibres.
Currently seven per cent of people survive their disease for five years or more.
People suffering from the disease might have more time with their loved ones when prescribed an immunotherapy drug currently used to treat several other types of cancer, new research has found.